Tema Oncology ETF
Limited financial coverage for CANC.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
- IPO
- 2023
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on CANC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $139.68M
- Div Yield
- 0.04%
- 52W High
- $45.35
- 52W Low
- $26.29
- 50D MA
- $40.89
- 200D MA
- $37.36
- Beta
- 0.70
- RSI (14)
- 63
- Avg Volume
- 33.51K
No earnings-call transcripts are available for CANC yet.
of shares held by institutions
12 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Thrivent Financial For Lutherans | 186.06K | ▲ 40.11K |
| Lpl Financial LLC | 138.82K | ▲ 36.55K |
| Hightower Advisors, LLC | 76.40K | ▲ 29.16K |
| Jane Street Group, LLC | 27.54K | ▼ 61.04K |
| Stratos Wealth Partners, Ltd. | 19.40K | ▲ 3.11K |
| Perennial Investment Advisors, LLC | 19.18K | ▲ 11.80K |
| Oder Investment Management, LLC | 12.40K | ▲ 12.40K |
| Royal Bank Of Canada | 7.85K | ▲ 7.85K |
| Wj Wealth Management, LLC | 6.85K | ▲ 6.85K |
| Cambridge Investment Research Advisors, Inc. | 5.33K | ▲ 5.33K |
| Roxbury Financial LLC | 3.94K | ▲ 3.02K |
| Us Bancorp \De\ | 600 | ▲ 600 |
Our CANC coverage
Recent articles, reports, and earnings notes.
No research on CANC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CANC report →Biotech ETF (CANC) Hits New 52-Week High
zacks.com · Aug 20
Tema ETFs Exceeds $5bn in AUM After Three Years
businesswire.com · Jun 15
Tema ETFs Surpasses $2 Billion in AUM in Under Three Years
businesswire.com · Apr 16
CANC: I Give A Hold Rating To This ETF That Invests In Cancer-Fighting Stocks
seekingalpha.com · Apr 10
Tema Appoints ETF Industry Leader Steve Munroe as President
businesswire.com · Feb 18
Thrivent Financial for Lutherans Decreases Stake in Tema Oncology ETF $CANC
defenseworld.net · Feb 8
Tema's Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance
businesswire.com · Dec 2
Be Thankful to These ETFs This Year
zacks.com · Nov 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.